2011Journal of International Obstetrics and GynecologyRequires access

Roles of EZH2 Histone Methyltransferase in Tumorigenesis

Di We

Open publisher page 0 citations

Abstract

The Polycomb group(PcG)protein family is a group of gene regulatory elements playing roles in embryonic development,which functioning in tow distinct protein complexes termed Polycomb-repressive complex 1(PRC1) and Polycomb-repressive complex 2(PRC2). EZH2 is the catalytic subunit of PRC2,which is a highly conserved histone methyltransferase that targets lysine-27 of histone H3. Most studies on human tumors show that EZH2 is over-expression in a variety of tumors,including prostate and breast. Although the mechanism of EZH2 with cancer progression is not determined,functional link between EZH2-mediated histone methylation and DNA methylation indicate which involved in the gene silencing machinery implicated in tumor suppressor loss. The authors review the basic molecular biology of EZH2 and the findings of EZH2 in different cancers. And also discuss EZH2 connections to other epigenetic modifying enzymes,as well as the consequences of EZH2 overabundance and its potential roles in tumorigenesis.

About this research paper

What this paper is about

The Polycomb group(PcG)protein family is a group of gene regulatory elements playing roles in embryonic development,which functioning in tow distinct protein complexes termed Polycomb-repressive complex 1(PRC1) and Polycomb-repressive complex 2(PRC2). EZH2 is the catalytic subunit of PRC2,which is a highly conserved histone methyltransferase that targets lysine-27 of histone H3. Most studies on human tumors show that EZH2 is over-expression in a variety of tumors,including prostate and breast. Although the mechanism of EZH2 with cancer progression is not determined,functional link between EZH2-mediated histone methylation and DNA methylation indicate which involved in the gene silencing machinery implicated in tumor suppressor loss. The authors review the basic molecular biology of EZH2 and the findings of EZH2 in different cancers. And also discuss EZH2 connections to other epigenetic modifying enzymes,as well as the consequences of EZH2 overabundance and its potential roles in tumorigenesis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The Polycomb group(PcG)protein family is a group of gene regulatory elements playing roles in embryonic development,which functioning in tow distinct protein complexes termed Polycomb-repressive complex 1(PRC1) and Polycomb-repressive complex 2(PRC2). EZH2 is the catalytic subunit of PRC2,which is a highly conserved histone methyltransferase that targets lysine-27 of histone H3. Most studies on human tumors show that EZH2 is over-expression in a variety of tumors,including prostate and breast. Although the mechanism of EZH2 with cancer progression is not determined,functional link between EZH2-mediated histone methylation and DNA methylation indicate which involved in the gene silencing machinery implicated in tumor suppressor loss. The authors review the basic molecular biology of EZH2 and the findings of EZH2 in different cancers. And also discuss EZH2 connections to other epigenetic modifying enzymes,as well as the consequences of EZH2 overabundance and its potential roles in tumorigenesis.

Key concepts: PRC2, EZH2, Histone methyltransferase, Histone H3, Biology, Polycomb-group proteins, Carcinogenesis, Epigenetics

Related papers

Back to paper searchBrowse research topicsOriginal source
Roles of EZH2 Histone Methyltransferase in Tumorigenesis — Research Paper | ScholarLens